Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

Cited In for PubMed (Select 15623449)

1.

Predicting complete response: is there a role for non-operative management of rectal cancer?

Yang TJ, Goodman KA.

J Gastrointest Oncol. 2015 Apr;6(2):241-6. doi: 10.3978/j.issn.2078-6891.2014.110. Review.

2.

Immunohistochemical detection of p53 expression in patients with preoperative chemoradiation for rectal cancer: association with prognosis.

Huh JW, Lee WY, Kim SH, Park YA, Cho YB, Yun SH, Kim HC, Park HC, Choi DH, Park JO, Park YS, Chun HK.

Yonsei Med J. 2015 Jan;56(1):82-8. doi: 10.3349/ymj.2015.56.1.82.

3.

Current approaches and challenges for monitoring treatment response in colon and rectal cancer.

McKeown E, Nelson DW, Johnson EK, Maykel JA, Stojadinovic A, Nissan A, Avital I, Brücher BL, Steele SR.

J Cancer. 2014 Jan 1;5(1):31-43. doi: 10.7150/jca.7987. Review.

4.

Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation.

Cai G, Xu Y, Zhu J, Gu WL, Zhang S, Ma XJ, Cai SJ, Zhang Z.

World J Gastroenterol. 2013 Sep 7;19(33):5520-7. doi: 10.3748/wjg.v19.i33.5520.

5.

Risk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancers.

Peng JY, Li ZN, Wang Y.

World J Gastroenterol. 2013 Aug 28;19(32):5227-37. doi: 10.3748/wjg.v19.i32.5227. Review.

6.

Single nucleotide polymorphisms in the HIF-1α gene and chemoradiotherapy of locally advanced rectal cancer.

Havelund BM, Spindler KL, Ploen J, Andersen RF, Jakobsen A.

Oncol Lett. 2012 Nov;4(5):1056-1060. Epub 2012 Jul 31.

7.

Treatment of locally advanced rectal cancer: controversies and questions.

Trakarnsanga A, Ithimakin S, Weiser MR.

World J Gastroenterol. 2012 Oct 21;18(39):5521-32. doi: 10.3748/wjg.v18.i39.5521. Review.

8.

Neoadjuvant treatment response as an early response indicator for patients with rectal cancer.

Park IJ, You YN, Agarwal A, Skibber JM, Rodriguez-Bigas MA, Eng C, Feig BW, Das P, Krishnan S, Crane CH, Hu CY, Chang GJ.

J Clin Oncol. 2012 May 20;30(15):1770-6. doi: 10.1200/JCO.2011.39.7901. Epub 2012 Apr 9.

9.

Predicting tumor response after preoperative chemoradiation using clinical parameters in rectal cancer.

Park CH, Kim HC, Cho YB, Yun SH, Lee WY, Park YS, Choi DH, Chun HK.

World J Gastroenterol. 2011 Dec 28;17(48):5310-6. doi: 10.3748/wjg.v17.i48.5310.

10.

Revisiting stapled and handsewn loop ileostomy closures: a large retrospective series.

Balik E, Eren T, Bugra D, Buyukuncu Y, Akyuz A, Yamaner S.

Clinics (Sao Paulo). 2011;66(11):1935-41.

11.

Recent advances in the management of carcinoma of the rectum.

Basu S, Srivastava V, Shukla VK.

Clin Exp Gastroenterol. 2009;2:49-60. Epub 2009 Jun 10.

12.

A pilot feasibility study of TNFerade™ biologic with capecitabine and radiation therapy followed by surgical resection for the treatment of rectal cancer.

Citrin D, Camphausen K, Wood BJ, Quezado M, Denobile J, Pingpank JF, Royal RE, Alexander HR, Seidel G, Steinberg SM, Shuttack Y, Libutti SK.

Oncology. 2010;79(5-6):382-8. doi: 10.1159/000323488. Epub 2011 Mar 25.

13.

Combination of SELDI-TOF-MS and data mining provides early-stage response prediction for rectal tumors undergoing multimodal neoadjuvant therapy.

Smith FM, Gallagher WM, Fox E, Stephens RB, Rexhepaj E, Petricoin EF 3rd, Liotta L, Kennedy MJ, Reynolds JV.

Ann Surg. 2007 Feb;245(2):259-66.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk